Skip to main content
. 2021 Aug 18;3(10):699–706. doi: 10.1002/acr2.11312

Figure 1.

Figure 1

Outcomes by C‐reactive protein (CRP) group. The percentage of patients reaching Assessment of Spondyloarthritis International (ASAS) 20 (A), ASAS40 (B), Ankylosing Spondylitis Disease Activity Score‐CRP (ASDAS‐CRP) (C), or Ankylosing Spondylitis Disease Activity Score‐Erythrocyte Sedimentation Rate (ASDAS‐ESR) (D) criteria for clinical improvement were plotted after being stratified into their appropriate baseline CRP levels. *Significant differences between the placebo and etanercept group (P < 0.05).